hotspot -WSS

hotspot

author：fashion 2025-10-01 04:10:31 - browse：4

Kuldeep Singh Rajput -- health tech coverage from STAT — Kuldeep Singh Rajput has left his role as CEO of Biofourmis. World Economic Forum

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.

A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic. The Boston-based company was valued at $1.3 billion following a $320 million Series D financing round which closed last summer and brought big names to Biofourmis: CVS Health was an investor, and Omar Ishrak, former CEO of Medtronic, and Sachin Jain, CEO of the SCAN Health Plan joined the board.

Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： A clever new way to fix Medicaid and graduate medical education

explore

WSS

Vaccine advisory panel ACIP left half staffed by HHS

HPV cancer vaccine study demonstrates efficacy

Readout LOUD podcast: How biotech is using artificial intelligence

The dental labor crisis is a moment of opportunity

MoonLake credibility takes another hit with mid

Biden report: The neurospychology of memory and aging

leisure time

hotspot

leisure time

Heart attack and stroke risk calculators need revising

Doctors' information doesn't help them choose wisely when sick

Jerome Adams on the need for new antivirals for Covid

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Duchenne breakthrough therapy leaves behind pioneering families

Excited delirium, Elijah McClain, and emergency physicians

Hollywood unions extend contract negotiations for actors

FDA approves potent Eli Lilly obesity drug, Zepbound

Hollywood unions extend contract negotiations for actors

Free speech concerns arise in wake of journal editor Eisen's firing

knowledge

HPV cancer vaccine study demonstrates efficacy

Medicare Advantage proposed rates disappoint insurers

Biotech incubator Curie.Bio graduates its first startup

PhRMA lawsuit over Medicare drug price negotiation tossed

PhRMA lawsuit over Medicare drug price negotiation tossed

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

explore

focus

Wikipedia

Wikipedia